カテゴリ： MarketLine, スイス, 企業調査

Givaudan SA：戦略・SWOT・企業財務分析

◆英語タイトル：Givaudan SA - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8014812
◆発行会社（調査会社）：MarketLine
◆発行日：2017年11月14日
◆ページ数：43
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スイス
◆産業分野：消費財
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Givaudan SA – Strategy, SWOT and Corporate Finance Report
Summary

Givaudan SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Givaudan S.A. (Givaudan) is a producer and marketer of fragrances and flavors. It is one of the leading flavor and fragrances companies in the world. The company offers a range of fragrances for fabric, personal care, hair and skin care, household and air care, oral care companies. Givaudan’s flavors find applications in beverages, savoury, snacks, sweet goods and dairy industries. It sells its products under various brands such as TasteSolutions, Givaudan Collections, TasteEssentials, ByNature and PureDelivery. The company, through its subsidiaries operates across Africa, the Middle East, Europe, North America, Latin America and Asia-Pacific regions. Givaudan is headquartered in Vernier, Switzerland.

Scope

- Detailed information on Givaudan SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Givaudan SA in the form of a SWOT analysis
- An in-depth view of the business model of Givaudan SA including a breakdown and examination of key business segments
- Intelligence on Givaudan SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Givaudan SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Givaudan SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Givaudan SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Givaudan SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Givaudan SA: Company Overview
Givaudan SA: Overview and Key Facts
Givaudan SA: Overview
Givaudan SA: Key Facts
Givaudan SA: Key Employees
Givaudan SA: Key Employee Biographies
Givaudan SA: Major Products and Services
Givaudan SA: Company History
Givaudan SA: Management Statement
Givaudan SA: Locations and Subsidiaries
Givaudan SA: Key Competitors
Givaudan SA: Company Analysis
Givaudan SA: Business Description
Givaudan SA: SWOT Analysis
Givaudan SA: SWOT Overview
Givaudan SA: Strengths
Givaudan SA: Weaknesses
Givaudan SA: Opportunities
Givaudan SA: Threats
Givaudan SA: Corporate Financial Deals Activity
Givaudan SA: Financial Deals Overview
Givaudan SA: Targets and Partners
Givaudan SA: Top Deals 2013 – 2017YTD*
Givaudan SA: Advisors
Givaudan SA: Top Financial Advisors
Givaudan SA: Mergers and Acquisitions
Givaudan SA: Corporate Venturing
Givaudan SA: Capital Raising
Givaudan SA: Partnership
Givaudan SA: Recent Developments
Givaudan SA: News and Events Summary
Givaudan SA: Business Expansion
Givaudan SA: Financial Deals
Givaudan SA: Financial Performance
Givaudan SA: Research & Development
Givaudan SA: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Givaudan SA: Key Facts
Table 2: Givaudan SA: Key Employees
Table 3: Givaudan SA: Locations and Subsidiaries
Table 4: Givaudan SA: Key Competitors
Table 5: Givaudan SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Givaudan SA: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Givaudan SA: M&A Average Deal Size - Value (US$m)
Table 8: Givaudan SA: Targets and Partners
Table 9: Givaudan SA: Top Deals 2013 - 2017YTD*
Table 10: Givaudan SA: Financial Advisor Ranking by Value (US$m)
Table 11: Givaudan SA: M&A Volume and Value Trend (2013 - YTD*2017)
Table 12: Givaudan SA: M&A Activity by Geography (2013 - YTD*2017)
Table 13: Givaudan SA: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 14: Givaudan SA: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 15: Givaudan SA: Capital Raising by Deal Type (2013 - YTD*2017)
Table 16: Givaudan SA: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 17: Givaudan SA: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 18: Givaudan SA: News and Events Summary
Table 19: Givaudan SA: Business Expansion
Table 20: Givaudan SA: Financial Deals
Table 21: Givaudan SA: Financial Performance
Table 22: Givaudan SA: Research & Development
Table 23: Givaudan SA: Strategy and Operations

★海外企業調査レポート[Givaudan SA：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Willis Towers Watson Public Ltd Co：戦略・SWOT・企業財務分析
    Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report Summary Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Stellar Biotechnologies Inc (SBOT)：医療機器：M&Aディール及び事業提携情報
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Oval Medical Technologies Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Oval Medical Technologies Ltd (Oval Medical), a subsidiary of SMC Ltd, is a developer of patient-centric autoinjectors. The company offers cyclic olefin polymeric (COP) drug containers, which are injection moulded for customization. Based on its subcutaneous platform, the company is developi …
  • Societe Tunisienne de l’Electricite et du Gaz：企業の戦略的SWOT分析
    Societe Tunisienne de l'Electricite et du Gaz - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Actividades de Construccion y Servicios SA：戦略・SWOT・企業財務分析
    Actividades de Construccion y Servicios SA - Strategy, SWOT and Corporate Finance Report Summary Actividades de Construccion y Servicios SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512)-医療機器分野：企業M&A・提携分析
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company’s pr …
  • The Leukemia & Lymphoma Society Inc-製薬・医療分野：企業M&A・提携分析
    Summary The Leukemia & Lymphoma Society Inc (LLS) is a health organization that offers funding research, finding cures and access to treatments for blood cancer patients. The organization’s services include patient support, health education, policy advocacy, funds raising and medical research fundin …
  • Municipal Energy Agency of Nebraska：企業の戦略的SWOT分析
    Municipal Energy Agency of Nebraska - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Akebia Therapeutics Inc (AKBA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • Allied Hotel Properties Inc：企業の戦略・SWOT・財務情報
    Allied Hotel Properties Inc - Strategy, SWOT and Corporate Finance Report Summary Allied Hotel Properties Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Harbin Electric Co Ltd (1133)：企業の財務・戦略的SWOT分析
    Harbin Electric Co Ltd (1133) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Blue Apron Holdings Inc (APRN)：企業の財務・戦略的SWOT分析
    Blue Apron Holdings Inc (APRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Edmond De Rothschild (Suisse) S.A.：企業の戦略・SWOT・財務分析
    Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • aTyr Pharma Inc (LIFE)：企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • ResApp Health Ltd (RAP)：企業の財務・戦略的SWOT分析
    ResApp Health Ltd (RAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • S.C. Johnson & Son Inc：戦略・SWOT・企業財務分析
    S.C. Johnson & Son Inc - Strategy, SWOT and Corporate Finance Report Summary S.C. Johnson & Son Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Land Securities Group Plc：企業のM&A・事業提携・投資動向
    Land Securities Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Land Securities Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • SEEK Limited：企業の戦略・SWOT・財務情報
    SEEK Limited - Strategy, SWOT and Corporate Finance Report Summary SEEK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Elsalys Biotech SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Elsalys Biotech SA (Elsalys Biotech) is a pharmaceutical company that develops new generation antibodies to modulate the immune system of patients with cancer or rare haematological diseases. The company's pipeline programs include anti-CD160, for macular degeneration or certain retinopathie …
  • FortisBC Inc：企業の戦略的SWOT分析
    FortisBC Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆